These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1012 related items for PubMed ID: 32096451

  • 21. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
    Iida O, Soga Y, Urasawa K, Saito S, Jaff MR, Wang H, Ookubo H, Yokoi H, MDT-2113 SFA Japan Investigators.
    J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
    [Abstract] [Full Text] [Related]

  • 22. The role for DCBs in the treatment of ISR.
    Bague N, Nasr B, Chaillou P, Costargent A, Gouailler-Vulcain F, Goueffic Y.
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):578-85. PubMed ID: 27102629
    [Abstract] [Full Text] [Related]

  • 23. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.
    Ouriel K, Adelman MA, Rosenfield K, Scheinert D, Brodmann M, Peña C, Geraghty P, Lee A, White R, Clair DG.
    JACC Cardiovasc Interv; 2019 Dec 23; 12(24):2515-2524. PubMed ID: 31575518
    [Abstract] [Full Text] [Related]

  • 24. Provisional Stenting Using the Zilver PTX Drug-Eluting Stent After Drug-Coated Balloon Angioplasty: Initial Experience From the Double Drug Dose "3D" Study.
    Fanelli F, Cannavale A, Citone M, Santoni M, Gazzetti M, Falcone GM, Miele V.
    J Endovasc Ther; 2020 Feb 23; 27(1):34-41. PubMed ID: 31637956
    [Abstract] [Full Text] [Related]

  • 25. Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry.
    Tepe G, Zeller T, Moscovic M, Corpataux JM, Christensen JK, Keirse K, Nano G, Schroeder H, Binkert CA, Brodmann M.
    J Endovasc Ther; 2020 Apr 23; 27(2):304-315. PubMed ID: 31989855
    [Abstract] [Full Text] [Related]

  • 26. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
    Schmidt A, Piorkowski M, Görner H, Steiner S, Bausback Y, Scheinert S, Banning-Eichenseer U, Staab H, Branzan D, Varcoe RL, Scheinert D.
    JACC Cardiovasc Interv; 2016 Apr 11; 9(7):715-24. PubMed ID: 27056311
    [Abstract] [Full Text] [Related]

  • 27. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
    Yu C, Tang W, Ren T, Chen Q, Lu R, Gao Y.
    J Endovasc Ther; 2024 Jun 11; 31(3):390-399. PubMed ID: 36189843
    [Abstract] [Full Text] [Related]

  • 28. Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology.
    Phair J, Carnevale M, Lipsitz EC, Shariff S, Scher L, Garg K.
    Ann Vasc Surg; 2020 Jul 11; 66():595-600. PubMed ID: 31863948
    [Abstract] [Full Text] [Related]

  • 29. A Pilot Study of Femoropopliteal Artery Revascularisation with a Low Dose Paclitaxel Coated Balloon: Is Predilatation Necessary?
    Schroeder H, Meyer DR, Lux B, Ruecker F, Martorana M, Miller LE, Duda S.
    Eur J Vasc Endovasc Surg; 2017 Sep 11; 54(3):348-355. PubMed ID: 28778456
    [Abstract] [Full Text] [Related]

  • 30. Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease.
    Herten M, Torsello GB, Schönefeld E, Stahlhoff S.
    Vasc Health Risk Manag; 2016 Sep 11; 12():341-56. PubMed ID: 27621646
    [Abstract] [Full Text] [Related]

  • 31. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.
    Sun G, Liu J, Jia S, Zhang J, Zhuang B, Jia X, Fu W, Wu D, Wang F, Zhao Y, Guo P, Bi W, Wang S, Guo W, AcoArt I Trial Investigators.
    Vascular; 2021 Jun 11; 29(3):340-349. PubMed ID: 32903168
    [Abstract] [Full Text] [Related]

  • 32. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E.
    J Endovasc Ther; 2014 Jun 11; 21(3):359-68. PubMed ID: 24915582
    [Abstract] [Full Text] [Related]

  • 33. Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions.
    Zeller T, Brechtel K, Meyer DR, Noory E, Beschorner U, Albrecht T.
    J Endovasc Ther; 2020 Oct 11; 27(5):683-690. PubMed ID: 32666871
    [Abstract] [Full Text] [Related]

  • 34. Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.
    Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, Metzger C, Micari A, Sachar R, Jaff MR, Wang H, Hasenbank MS, Krishnan P, IN.PACT SFA Trial Investigators.
    Circ Cardiovasc Interv; 2018 Jan 11; 11(1):e005891. PubMed ID: 29326153
    [Abstract] [Full Text] [Related]

  • 35. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
    Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.
    JACC Cardiovasc Interv; 2013 Dec 11; 6(12):1295-302. PubMed ID: 24239203
    [Abstract] [Full Text] [Related]

  • 36. IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population.
    Chen Z, Guo W, Jiang W, Wang F, Fu W, Zou Y, Deckers S, Li P, Popma JJ, Jaff MR.
    J Endovasc Ther; 2019 Aug 11; 26(4):471-478. PubMed ID: 31204595
    [Abstract] [Full Text] [Related]

  • 37. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study.
    Liistro F, Angioli P, Porto I, Ricci L, Ducci K, Grotti S, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.
    J Endovasc Ther; 2014 Feb 11; 21(1):1-8. PubMed ID: 24502477
    [Abstract] [Full Text] [Related]

  • 38. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
    Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G.
    Circ Cardiovasc Interv; 2019 Jun 11; 12(6):e007702. PubMed ID: 31195825
    [Abstract] [Full Text] [Related]

  • 39. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
    Shammas NW, Shammas GA, Jones-Miller S, Shammas WJ, Bou-Dargham B, Shammas AN, Banerjee S, Rachwan RJ, Daher GE.
    Cardiovasc Revasc Med; 2018 Oct 11; 19(7 Pt A):771-777. PubMed ID: 30420096
    [Abstract] [Full Text] [Related]

  • 40. Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.
    Schroë H, Holden AH, Goueffic Y, Jansen SJ, Peeters P, Keirse K, Ito W, Vermassen F, Micari A, Blessing E, Jaff MR, Zeller T.
    Catheter Cardiovasc Interv; 2018 Feb 15; 91(3):497-504. PubMed ID: 29086462
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.